Display
Language
About accessibility
Language
Display
Sign in

Bills › 91st General Assembly

HF 950Died when the session ended · March 12, 2025

Relating to hemp products and the definition, possession, and allowable forms of medical cannabidiol

Sponsored by the House Health and Human Services Committee, Rep. Hans C. Wilz (R)

Topics:Alcohol, cannabis & gamingHealth care

Same legislation: HF 105, SF 163

Write your legislators about it

Also covers HF 105 and SF 163.

Official bill pageLobbyist declarationsOne-pager to print

Where it is now

  1. Done: IntroducedJanuary 22, 2025
  2. Done: SubcommitteeJanuary 22, 2025
  3. Done: House committeeMarch 5, 2025
  4. Stopped: Passes the HouseDied when the General Assembly ended
  5. Next: Senate committeeFunnel: by March 20, 2026
  6. Next: Passes the Senate
  7. Next: To the Governor
  8. Next: Signed into law

Died when the session ended The 2026 session adjourned on May 3, 2026, the General Assembly’s last regular session. Bills that didn’t pass both chambers died. What’s a funnel?

What’s in it

AI summary New rules would allow medical cannabidiol to include inhalable plant flowers. Dispensaries cannot give these inhalable products to anyone under 21, and the state will set specific rules for how vaporizable products are packaged. Patients and caregivers must also follow strict limits on how much THC they can possess at one time.1

Read the official explanation

This bill relates to hemp products and the definition, possession, and allowable forms of medical cannabidiol. or Cannabis indica in inhalable form. The bill requires the medical cannabidiol board to create packaging requirements for vaporizable medical cannabidiol and prohibits a medical cannabidiol dispensary from dispensing inhalable forms of medical cannabidiol to patients under 21 years of age. The bill requires a medical cannabidiol registration card to include a statement that a patient or primary caregiver shall not possess more total tetrahydrocannabinol than the patient or primary caregiver is allowed to purchase in a 90-day period. The bill changes the affirmative defenses available to medical cannabidiol patients and primary caregivers to only apply when the patient or primary caregiver does not possess more total tetrahydrocannabinol than the patient or primary caregiver is allowed to purchase in a 90-day period. The bill does not limit a person from manufacturing, selling, or possessing a hemp product as authorized by Code chapter 204 (hemp and hemp products).

Why it matters. Medical cannabidiol patients and caregivers would face new limits on the total amount of tetrahydrocannabinol they can possess based on their 90-day purchase allowance. Medical cannabidiol dispensaries would be prohibited from providing inhalable forms of the product to patients under 18 years of age, and the medical cannabidiol board would be responsible for creating new packaging requirements for vaporizable products.2

Full bill text3

4 written public comments to its subcommittee: January 27, 2025 (4) · on the Legislature’s site

Iowa Code it changes

Amends§124E.12§124E.2§124E.26§124E.4§124E.5§124E.9

How the Code works4

Lobbying

7 for · 2 against · 10 undecided · Who →

Family tree

Tried before

HSB 532Cleared committee90th GA

91st General Assembly

HF 105RenumberedHouse companionSF 163Cleared committeeSenate companionHF 950Cleared committeefrom HF 105

Earlier and later bills are matched by wording or an identical title.

Tried before

This idea has been filed in an earlier General Assembly. None got through a chamber.

  • HSB 532 HSB 532
    90th General Assembly · Subcommittee recommends passage · very similar
    Cleared committee

Matched by wording or an identical title.